Movement Alert｜WUXI XDC Falls 3.05% in Regular Trading, Life Sciences Tools & Services Weakness Weighs on Shares

Market Focus10-23

On October 23, WUXI XDC fell 3.05% in regular trading, trading at HK$66.85 per share, with turnover of HK$39.32 million.

The move aligns with broad weakness across the Life Sciences Tools & Services segment rather than a newly disclosed company-specific negative catalyst.

Recent market updates indicated the company had no fresh clear adverse news, while peers in the same segment also declined, including GENSCRIPT B-1K falling 9.98%, INSILICO falling 4.83%, XTALPI falling 3.33%, WUXI BIO falling 3.09%, and WUXI APPTEC falling 2.23%. Earlier disclosed interim results showed first-half revenue of RMB3.701 billion, up 37.0%, and adjusted net profit of RMB1.027 billion, up 37.4%. A prior broker note maintained a Buy rating with a target price of HK$97.90.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment